Morning Market Losers

Net Element

declined 24.89% to $4.28. Net Element has eliminated $15 million of debt from its balance sheet. NPS Pharmaceuticals

shares dipped 12.26% to $28.69. The FDA has voted 8-5 in favor of NPS Pharmaceuticals' Natpara. Bankrate

slipped 10.58% to $12.36 after the company named Steven Barnhart as interim Chief Financial Officer and announced the SEC investigation relating to 2012 financial reporting. Achillion Pharmaceuticals

shares fell 9.85% to $10.98 after dropping 3.87% on Friday. Terex

shares dropped 6.40% to $32.48 after the company lowered its 2014 earnings forecast. MDU Resources Group

shares fell 5.60% to $28.48 after the company cut its 2014 earnings outlook. Cree

declined 3.54% to $41.17. Goldman Sachs downgraded from Buy to Neutral and lowered the target price from $60 to $48. Symantec

shares slipped 2.41% to $23.94. Analysts at RBC Capital downgraded Symantec from Outperform to Sector Perform. Gilead Sciences

shares declined 1.76% to $101.84 after the company reported that it has signed licensing agreements with seven India-based generic pharmaceutical manufacturers to expand access to its hepatitis C treatments in developing countries.